company background image
OSP

Osprey MedicalASX:OSP Stock Report

Market Cap

AU$24.4m

7D

10.5%

1Y

-63.5%

Updated

20 Oct, 2021

Data

Company Financials
OSP fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

OSP Overview

Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for Osprey Medical
Historical stock prices
Current Share PriceAU$0.95
52 Week HighAU$0.76
52 Week LowAU$2.80
Beta1.17
1 Month Change21.80%
3 Month Change-40.63%
1 Year Change-63.46%
3 Year Change-95.13%
5 Year Change-97.71%
Change since IPO-97.74%

Recent News & Updates

Shareholder Returns

OSPAU Medical EquipmentAU Market
7D10.5%2.1%1.5%
1Y-63.5%-6.3%21.1%

Return vs Industry: OSP underperformed the Australian Medical Equipment industry which returned -6.5% over the past year.

Return vs Market: OSP underperformed the Australian Market which returned 20.2% over the past year.

Price Volatility

Is OSP's price volatile compared to industry and market?
OSP volatility
OSP Beta1.17
Industry Beta0.57
Market Beta1

Stable Share Price: OSP is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 14% a week.

Volatility Over Time: OSP's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2005n/aMike McCormickhttps://www.ospreymed.com

Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers AVERT, AVERT Plus, DyeVert NG, DyeVert Plus System, and DyeVert Plus EZ Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.

Osprey Medical Fundamentals Summary

How do Osprey Medical's earnings and revenue compare to its market cap?
OSP fundamental statistics
Market CapUS$18.22m
Earnings (TTM)-US$11.12m
Revenue (TTM)US$1.94m

9.4x

P/S Ratio

-1.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
OSP income statement (TTM)
RevenueUS$1.94m
Cost of RevenueUS$1.31m
Gross ProfitUS$630.86k
ExpensesUS$11.75m
Earnings-US$11.12m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.43
Gross Margin32.53%
Net Profit Margin-573.52%
Debt/Equity Ratio11.1%

How did OSP perform over the long term?

See historical performance and comparison

Valuation

Is Osprey Medical undervalued compared to its fair value and its price relative to the market?

1.87x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate OSP's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate OSP's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: OSP is unprofitable, so we can't compare its PE Ratio to the Australian Medical Equipment industry average.

PE vs Market: OSP is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate OSP's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: OSP is good value based on its PB Ratio (1.9x) compared to the AU Medical Equipment industry average (5x).


Future Growth

How is Osprey Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Osprey Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Osprey Medical performed over the past 5 years?

-3.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: OSP is currently unprofitable.

Growing Profit Margin: OSP is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: OSP is unprofitable, and losses have increased over the past 5 years at a rate of 3.4% per year.

Accelerating Growth: Unable to compare OSP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OSP is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (74.9%).


Return on Equity

High ROE: OSP has a negative Return on Equity (-114.17%), as it is currently unprofitable.


Financial Health

How is Osprey Medical's financial position?


Financial Position Analysis

Short Term Liabilities: OSP's short term assets ($12.1M) exceed its short term liabilities ($2.0M).

Long Term Liabilities: OSP's short term assets ($12.1M) exceed its long term liabilities ($1.2M).


Debt to Equity History and Analysis

Debt Level: OSP's debt to equity ratio (11.1%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if OSP's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OSP has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: OSP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.2% each year


Dividend

What is Osprey Medical current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate OSP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate OSP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if OSP's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OSP's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of OSP's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

10.3yrs

Average management tenure


CEO

Mike McCormick (59 yo)

11.58yrs

Tenure

US$612,267

Compensation

Mr. Michael McCormick, also known as Mike has been the President and Chief Executive Officer of Osprey Medical Inc. since March 2010. Mr. McCormick has more than 20 years of experience in the medical devic...


Leadership Team

Experienced Management: OSP's management team is seasoned and experienced (10.3 years average tenure).


Board Members

Experienced Board: OSP's board of directors are considered experienced (9.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 71.2%.


Top Shareholders

Company Information

Osprey Medical, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Osprey Medical, Inc.
  • Ticker: OSP
  • Exchange: ASX
  • Founded: 2005
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: AU$24.376m
  • Shares outstanding: 25.66m
  • Website: https://www.ospreymed.com

Location

  • Osprey Medical, Inc.
  • 5600 Rowland Road
  • Suite 250
  • Minnetonka
  • Minnesota
  • 55343
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/20 15:28
End of Day Share Price2021/10/20 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.